Author： Wilson Michelle K. Karakasis Katherine Oza Amit M.
Publisher： Blackwell Publishing
E-ISSN： 1097-0142|121|18|3360-3361
ISSN： 0008-543X
Source： Cancer, Vol.121, Iss.18, 2015-09, pp. : 3360-3361
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Reply to discrepancies in drug approvals: A global dilemma
By Ezeife Doreen A. Truong Tony H. Tang Patricia A.
Cancer, Vol. 121, Iss. 18, 2015-09 ,pp. :
Access to resources
Recommend
US drug approvals driven by science or commerce?
Reactions Weekly, Vol. 1, Iss. 1167, 2007-01 ,pp. :
The US FDA is responsible for the down-turn in new drug approvals
Inpharma, Vol. 1, Iss. 1646, 2008-01 ,pp. :
US drug approvals driven by science or commerce?
Inpharma, Vol. 1, Iss. 1602, 2007-01 ,pp. :